Edition:
United States

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

77.27USD
18 Aug 2017
Change (% chg)

$-0.42 (-0.54%)
Prev Close
$77.69
Open
$77.59
Day's High
$78.73
Day's Low
$77.26
Volume
423,761
Avg. Vol
448,874
52-wk High
$99.13
52-wk Low
$63.69

Latest Key Developments (Source: Significant Developments)

Perrigo announces FDA final approval for its AB rated generic version of mycolog® II cream
Wednesday, 16 Aug 2017 08:52am EDT 

Aug 16 (Reuters) - Perrigo Company Plc :Perrigo announces FDA final approval for its AB rated generic version of mycolog® II cream.Perrigo Company Plc - ‍Company anticipates launching this product in Q4 of 2017​.  Full Article

Perrigo says Rx segment, year-over-year price erosion assumption remains at 9 pct to 11 pct
Thursday, 10 Aug 2017 01:19pm EDT 

Aug 10 (Reuters) - Perrigo Company Plc :Perrigo says Rx segment, year-over-year price erosion assumption remains at 9 percent to 11 percent - Conf Call.Perrigo says expected net sales forecast increased in the Rx segment to nearly $900 million due to earlier than expected launch of new products.  Full Article

SK Capital announces deal to acquire Perrigo Company plc’s active pharmaceutical ingredients business
Thursday, 10 Aug 2017 10:39am EDT 

Aug 10 (Reuters) - SK Capital: :SK Capital announces agreement to acquire Perrigo Company plc’s active pharmaceutical ingredients business.SK Capital announces agreement to acquire Perrigo Company plc's active pharmaceutical ingredients business​.Parties have agreed to enter into long-term supply agreement for Perrigo API to supply multiple existing commercial, pipeline APIs to Perrigo.Transaction is expected to close during Q4 2017, before which a new trade name will be selected and announced for business ​.Four israeli pharmaceutical executives will be joining board of directors of Perrigo API in partnership with SK Capital​.  Full Article

Perrigo updates on restructuring charges related to its workforce reduction plan
Thursday, 10 Aug 2017 09:40am EDT 

Aug 10 (Reuters) - Perrigo Company Plc :Perrigo - In connection with workforce reduction plan, estimates it will recognize total pre-tax restructuring charges of about $55 million to $65 million.Perrigo - Expect to incur majority of remaining charges in 2017, with balance to be recognized during q1 of year ending December 31, 2018.  Full Article

Perrigo Q2 loss per share $0.49
Thursday, 10 Aug 2017 02:03am EDT 

Aug 10 (Reuters) - Perrigo Company Plc :Perrigo company plc reports second quarter 2017 financial results.Q2 loss per share $0.49.Q2 sales $1.2 billion versus i/b/e/s view $1.18 billion.Q2 earnings per share view $0.93 -- Thomson Reuters I/B/E/S.Sees FY 2017 adjusted earnings per share $4.45 to $4.70.Sees FY 2017 earnings per share $0.84 to $1.09.Q2 adjusted earnings per share $1.22 excluding items.Reached an agreement to divest israel active pharmaceutical ingredient (api) business for $110 million in cash.  Full Article

Perrigo Company sets quarterly dividend of $0.16/share
Tuesday, 8 Aug 2017 10:52am EDT 

Aug 8 (Reuters) - Perrigo Company PLC ::Sets quarterly dividend of $0.16per share.  Full Article

Perrigo announces tentative FDA approval for generic version of Mirvaso
Friday, 4 Aug 2017 09:21am EDT 

Aug 4 (Reuters) - Perrigo Company Plc :Perrigo announces tentative FDA approval for generic version of Mirvaso gel.Perrigo Company PLC - received tentative approval from U.S. FDA for generic version of Mirvaso (brimonidine) topical gel 0.33%.  Full Article

Perrigo announces the launch of the AB rated generic version of Transderm Scop 1.5 mg
Monday, 31 Jul 2017 09:21am EDT 

July 31 (Reuters) - Perrigo Company Plc :Perrigo announces the launch of the AB rated generic version of Transderm Scop 1.5 mg.Perrigo Company - co, co-development partner aveva drug delivery announced prescription pharmaceutical launch of scopolamine 1.5 mg transdermal system patch.  Full Article

Perrigo says board suspends CFO search during search for John Hendrickson's successor as CEO - SEC Filing
Friday, 21 Jul 2017 06:09pm EDT 

July 21 (Reuters) - Perrigo Company Plc :Perrigo company plc says on march 8, 2017, remuneration committee of board approved changes to acting cfo ronald winowiecki's compensation.Perrigo -although winowiecki remains key candidate for permanent cfo, board suspended its cfo search during its search for hendrickson's successor as ceo.  Full Article

Perrigo confirms patent challenge for generic version of Soolantra cream, 1 pct
Monday, 17 Jul 2017 09:08am EDT 

July 17 (Reuters) - Perrigo Company Plc ::Perrigo confirms patent challenge for generic version of Soolantra cream, 1%.Perrigo - unit filed paragraph IV abbreviated new drug application with U.S. FDA for a generic version of soolantra cream, 1%​.  Full Article

BRIEF-Perrigo announces FDA final approval for its AB rated generic version of mycolog® II cream

* Perrigo announces FDA final approval for its AB rated generic version of mycolog® II cream